These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 11943110)
1. [Drugs and cost-effectiveness]. Marín Moreno S Med Clin (Barc); 2002 Mar; 118(11):438; author reply 438-9. PubMed ID: 11943110 [No Abstract] [Full Text] [Related]
2. [The need for joint evaluation of pharmaceutical expenditure and the health outcomes obtained]. Soto Álvarez J Gac Sanit; 2011; 25(3):257. PubMed ID: 21459490 [No Abstract] [Full Text] [Related]
3. [Drug utilization decisions should be based on cost-benefit data]. Bengt J; Arvidsson G; Levin LA; Rehnberg C Lakartidningen; 2005 Apr 18-24; 102(16):1264-5; discussion 1265. PubMed ID: 15921102 [No Abstract] [Full Text] [Related]
4. When is it cost-effective to change the behavior of health professionals? Mason J; Freemantle N; Nazareth I; Eccles M; Haines A; Drummond M JAMA; 2001 Dec; 286(23):2988-92. PubMed ID: 11743840 [TBL] [Abstract][Full Text] [Related]
5. [Cost-effective drug utilization--what can the national drug agency do?]. Wesenberg GR; Madsen S Tidsskr Nor Laegeforen; 2001 Aug; 121(18):2207. PubMed ID: 11572010 [No Abstract] [Full Text] [Related]
6. The costs of making practice more cost-effective. Weeks WB; Wallace AE JAMA; 2002 Apr; 287(13):1648; author reply 1649-50. PubMed ID: 11926883 [No Abstract] [Full Text] [Related]
7. The economic aspects of drug use. Haaijer-Ruskamp FM; Dukes MN WHO Reg Publ Eur Ser; 1993; 45():125-45. PubMed ID: 8442842 [No Abstract] [Full Text] [Related]
8. [Measures to contain drug costs and quality indicators in the use of drugs: prescribe less or prescribe better?]. Arnau JM Aten Primaria; 1994 Mar; 13(4):155-8. PubMed ID: 8180298 [No Abstract] [Full Text] [Related]
9. Insurance issues and new treatments. Neels K J Am Dent Assoc; 1994 Jan; 125 Suppl():45S-53S. PubMed ID: 8294675 [No Abstract] [Full Text] [Related]
10. Serving patient needs while implementing cost effectiveness programs in health care administration. Tootelian DH Health Mark Q; 1994; 11(3-4):161-73. PubMed ID: 10137013 [TBL] [Abstract][Full Text] [Related]
11. The effects of copayments and generic substitution on the use and costs of prescription drugs. Smith DG Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607 [TBL] [Abstract][Full Text] [Related]
12. [Consumption of drugs: policies and social pact]. Antoñanzas Villar F Gac Sanit; 2000; 14(2):93-6. PubMed ID: 11203054 [No Abstract] [Full Text] [Related]
13. A review of limited lists and formularies: are they cost-effective? Pearce MJ; Begg EJ Pharmacoeconomics; 1992 Mar; 1(3):191-202. PubMed ID: 10147029 [TBL] [Abstract][Full Text] [Related]
14. [Five experts interviewed about drugs. Benefits for the patients could have been more emphasized]. Melander A Lakartidningen; 2002 Feb; 99(9):872-3. PubMed ID: 11962005 [No Abstract] [Full Text] [Related]
15. [Containing pharmacy costs in an emergency department]. Ucha Samartín M; Martínez López de Castro N; Pichel Loureiro A; Amador Barciela L Rev Calid Asist; 2012; 27(5):298-9. PubMed ID: 22704689 [No Abstract] [Full Text] [Related]
16. [Antibiotics in Valencian Community: controlling expenditure but not consumption]. Colomina-Rodríguez J; Gil-Tomás JJ; Pérez-Doñate V; Borrás-Máñez M Rev Esp Quimioter; 2014 Sep; 27(3):227-9. PubMed ID: 25229382 [No Abstract] [Full Text] [Related]
17. Physicians, Accountable Care, And Drugs. Weil AR Health Aff (Millwood); 2016 Mar; 35(3):387. PubMed ID: 26953288 [No Abstract] [Full Text] [Related]
18. [Cost-effective drug utilization--thiazides are still available]. Lund-Roland L Tidsskr Nor Laegeforen; 2001 Sep; 121(22):2637. PubMed ID: 11668768 [No Abstract] [Full Text] [Related]
19. Does antidepressant step therapy fuel the law of unintended consequences? Greden JF Am J Psychiatry; 2010 Oct; 167(10):1148-51. PubMed ID: 20889657 [No Abstract] [Full Text] [Related]